Comparative Analysis of Profit Model of Typical Pharmaceutical O2O Enterprises in China

Qu Simeng , Wang Shuling

Asian Journal of Social Pharmacy ›› 2024, Vol. 19 ›› Issue (1) : 81 -88.

Asian Journal of Social Pharmacy ›› 2024, Vol. 19 ›› Issue (1) :81 -88.
research-article
Comparative Analysis of Profit Model of Typical Pharmaceutical O2O Enterprises in China
Author information +
History +

Abstract

Objective To study the profit model of Chinese pharmaceutical O2O enterprises. Methods A case study of three typical pharmaceutical O2O enterprises was conducted, and their profit models were compared. Results and Conclusion The pharmaceutical O2O enterprises in China are divided into three categories according to the profit models. It is found that the current pharmaceutical O2O enterprises have problems such as simple profit model and low corporate profits. Based on these problems, it is recommended that relevant enterprises develop various business models to increase profit channels. Besides, they should establish and improve internal cost control systems.

Keywords

pharmaceutical O2O / profit model / case analysis

Cite this article

Download citation ▾
Qu Simeng, Wang Shuling. Comparative Analysis of Profit Model of Typical Pharmaceutical O2O Enterprises in China. Asian Journal of Social Pharmacy, 2024, 19(1): 81-88 DOI:

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Kang Kai. New retail mode: E-commerce is favored by thousands, and entities are not afraid of it[J]. China Pharmacy, 2021 (9): 102-104.

[2]

Zhang Jinwei, Hu Shuchen, Xu Zhengze, et al. Literature research and suggestions on the development status of online pharmacies in my country[J]. China Pharmacy, 2021, 32 (14): 1678-1684.

[3]

Yao Zong. The transformation of the pharmaceutical distribution industry to high-quality development is more obvious[N]. International Business Daily, 2021-08-02 (001).

[4]

Li Yicai, Xie Aili. Research on the profit model of B2C self-operated online pharmacies based on big data technology[J]. China Business Review, 2020 (24): 57-59.

[5]

Liu Qiufeng, Tian Kan, Shen Xikun, et al. Innovative research on the O2O business model of drug distribution under the background of “Internet +”[J]. China Journal of Health Information Management, 2018, 15 (4): 447-451.

[6]

Wu Mengyue. O2O, the next incremental point for pharmacies[J]. China Pharmacy, 2019 (10): 63.

[7]

Zhao Anqi. Ehaoyaoopens up online and offline[J]. China Pharmacy, 2020 (8): 64-65.

[8]

Huang Zhenzhen, Wang Xin. Big health map of internet giants[J]. Enterprise Management, 2021 (9): 63-69.

[9]

Su Mingli. The advantages of online pharmacies under the epidemic[J]. Computer and Network, 2020, 46 (5): 6-7.

[10]

Qin Zhidong. Dingdang Kuaiyao submits its IPO prospectus to the geometry of the odds of winning the internet health track[J]. Computer and Network, 2021, 47 (13): 4-5.

[11]

Li Xiuzhi. Medical veterans start again[J]. Chinese Entrepreneurs, 2020 (7): 50-52.

[12]

Bao Guiying. Analysis of profit model of O2O platform[J]. Contemporary County Economy, 2021 (5): 98-99.

[13]

Li Shiyang, Dan Bin. Research on multi-channel operation mode and influencing factors of drug chain retail enterprises[J]. Journal of Chongqing University (Social Science Edition), 2016, 22 (3): 82-88.

[14]

Wang Zhijin. How to break the new retail of small and medium-sized enterprises[J]. China Pharmacy, 2021 (5): 59-61.

[15]

Li Manyu. Research on the profit model of O2O E-commerce enterprises - taking Suning Tesco as an example[J]. Modern Commerce and Industry, 2020, 41 (21): 36-38.

14

Accesses

0

Citation

Detail

Sections
Recommended

/